Owner Synta Pharmaceuticals Corp.

Inventors Jiang, Jun; Kowalczyk-Przewloka, Teresa; Schweizer, Stefan M.; Xia, ZhiQiang; Chen, Shoujun; Borella, Christopher; Sun, Lijun

Agent Davies Collison Cave

Pub. Number AU-A-2009322603

PCT Pub. Number WO2010/065512

Priority 61/200,526 01.12.08 US

Filing date 1 December 2009

Wipo publication date 10 June 2010

C07C 327/56 (2006.01) Thiocarboxylic acids

A61K 31/175 (2006.01)

A61K 31/36 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61P 35/00 (2006.01) Antineoplastic agents

C07D 213/86 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 263/34 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 295/16 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 317/62 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms